期刊文献+

某综合性医院抑酸药物的专项处方点评 被引量:2

Specific Audit on Prescriptions of Acid-inhibitory Drug in One General Hospital
原文传递
导出
摘要 目的:了解我院质子泵抑制剂及 H2受体拮抗剂抑酸药的临床使用情况,实现医疗质量持续改进。方法:以药品说明书为依据,利用临床药学工作软件统计分析煤炭总医院2013年1-3月抑酸药临床使用情况。结果:抑酸药处方合格率为63.0%:其中门急诊处方合格率为60.1%,住院医嘱合格率为71.3%。结论:医疗机构开展专项处方点评势在必行,并以此规范医师的处方行为,明确药师的审方责任,促进临床合理使用药品,保证患者用药安全。 Objective: To study the clinical use of acid-inhibitory drugs including the proton pump inhibitors and H2 receptor antagonist and to make continuous quality improvement in the hospital. Methods: Based on the drug instruction, to analyze the clinical use of acid-inhibitory drugs from Jan to March of 2013 in the Coal General Hospital by using Clinical Pharmacy Software. Results:The percentage of eligibility for acid inhibitory drugs prescriptions is 63% and 60.1% for outpatient prescriptions, 71.3% for hospitalization ones. Conclusion: it is necessary to carry out the specific audit on prescription to regulate the prescription behaviors of doctors. To make clear of the pharmacist responsibility, to promote the rational clinical use of drugs and to guarantee the safety of patients.
出处 《临床药物治疗杂志》 2014年第3期55-59,共5页 Clinical Medication Journal
基金 北京药学会临床药学资助项目(2013年)
关键词 抑酸药 专项处方点评 药品风险管理 acid-inhibitory drug specific prescription audit drug risk management
  • 相关文献

参考文献11

  • 1诸骏仁,桑国卫.中华人民共和国药典临床用药须知化学药和生物制品卷[M].2005年版.北京:人民卫生出版社,2005:267-284.
  • 2Klotz U. Proton pump inhibitors--their pharmacological impact on the clinical management of acid-related disorders[J]. Arzneimittelforschung, 2009, 59(6):271-282.
  • 3Gashi Z, Haziri A, Berisha D, et al. Effectiveness of proton pump inhibitors in the treatment of patients with endoscopic esophagitis[J]. Med Arh, 2010, 64(6):362-364.
  • 4Romano C, Chiaro A, Comito D, et al. Proton pump inhibitors in pediatrics: evaluation of efficacy in GERD therapy[J]. Curr Clin Pharmacol, 2011, 6(1):41-47.
  • 5陈新谦,金有豫,汤光.新编药物学[M].17版.北京:人民卫生出版社,2011:3465.
  • 6张艳.奥美拉唑静滴、静注须区分[N].基层医院,2012年12月10日D23版.
  • 7李静.质子泵抑制剂——泮托拉唑[J].中国药学杂志,2001,36(10):710-711. 被引量:23
  • 8杨丽,严宝霞.埃索美拉唑的药动学[J].中国新药杂志,2004,13(5):398-400. 被引量:60
  • 9樊春艳,徐光奇,吴金虎.pH值对法莫替丁氯化钠注射液稳定性的影响[J].山东医药工业,2001,20(3):13-15. 被引量:7
  • 10Philip O. Katz.Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease[J]. Am J Gastroenterol, 2013, 3(108):308-328.

二级参考文献19

  • 1楼雅卿,赵莉,张远.中国健康志愿者的奥美拉唑及其代谢物的药代动力学研究[J].中国临床药理学杂志,1994,10(1):14-21. 被引量:27
  • 2Mckenie CA, Barnes CL, Boyd JA, et al. Unlabeled uses for approved drug. Pharmacist, 1993, 18: 49.
  • 3Mundy GB, Fleckenstein L, Mazzullo JM, et al. Current medical practice and the food and drug administration: some evidence for the existing gap. JAMA, 1974, 229: 1774.
  • 4American Society of Hospital Pharmacists. ASHP statement on the use of medications for unlabeled uses. Am J Hospital Pharm,1992, 49: 2006.
  • 5Torres A. The use of food and drug administration-approved medications for unlabeled (off-label) uses. Arch Dermatol, 1994,130: 32.
  • 6Drug Facts and Comparisons. Drug Facts and comparison.51th ed.St Louis: A Wolters Kluwer Company, 1997. 3491.
  • 7Drug Facts and Comparisons. Drug Facts and comparison. 57th ed. St Louis: A Wolters Kluwer Company, 2003. 1740.
  • 8Health Care Financing Administration. Medicare Carriers'manual. Section2050.5. Washington DC: U.S. Department of Health and Human Services, 1987 .
  • 9Beauchamp TL, Childress JE. Principles of Biomedical Ethics.2nd ed. New York: Oxford University Press, 1983.60, 159, 330.
  • 10Laeta T, Silberman G. Reimbursement policies constrain the practice of oncology. JAMA, 1991, 266: 2996.

共引文献970

同被引文献13

引证文献2

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部